WHO Guideline on the Use and Indications of GLP-1 Therapies for the Treatment of Obesity in Adults
Falha ao colocar no Carrinho.
Tente novamente mais tarde
Falha ao adicionar à Lista de Desejos.
Tente novamente mais tarde
Falha ao remover da Lista de Desejos
Tente novamente mais tarde
Falha ao adicionar à Biblioteca
Tente outra vez
Falha ao seguir podcast
Tente outra vez
Falha ao parar de seguir podcast
Tente outra vez
WHO Guideline on the Use and Indications of GLP-1 Therapies for the Treatment of Obesity in Adults
-
Narrado por:
-
De:
Sobre este título
Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease. WHO recently published a guideline in JAMA on the use and indications of GLP-1 therapies for the treatment of #obesity in adults. Francesca Celletti, MD, PhD, and Ezekiel Emanuel, MD, PhD, join JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss.
Related Content:
- World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
Ainda não há avaliações